Status
Conditions
Treatments
About
The single-arm continued access phase will be used to collect additional effectiveness and safety data to support the objectives and outcomes of the original IDE pivotal study.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Subject requiring all of the following at the time of transplantation:
Subject has acute/fulminant liver failure (UNOS status 1A)
Subject undergoing simultaneous transplantation of more than one organ (e.g., liver and kidney)
Subject is pregnant (as confirmed by urine or serum pregnancy test) or nursing
Concurrent enrollment in another clinical trial. Subjects enrolled in clinical trials or registries where only measurements and/or samples are taken (NO TEST DEVICE or TEST DRUG USED) are allowed to participate.
Primary purpose
Allocation
Interventional model
Masking
19 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal